Chimerix Inc is a biopharmaceutical company dedicated to developing innovative antiviral therapies aimed at addressing significant unmet medical needs, particularly in patients with compromised immune systems. The company focuses on advancing its proprietary drug candidates that target viral infections, with a substantial emphasis on conditions such as cytomegalovirus and other serious viral pathogens. Through advanced research and development, Chimerix aims to enhance the quality of life for patients undergoing treatments like stem cell transplants or those affected by other severe health challenges, thus contributing to the broader landscape of infectious disease management and treatment.